Monitoring of gastrointestinal carcinoma via molecular residual disease with circulating tumor DNA using a tumor‐informed assay

Monitoring of gastrointestinal carcinoma via molecular residual disease with circulating tumor DNA using a tumor‐informed assay

Abstract Background Circulating tumor DNA (ctDNA)‐based minimal residual disease (MRD) detection, which can identify disease relapse ahead of radiological imaging, has shown promising performance. The objective of this study was to develop and validate OriMIRACLE S (Minimal Residual Circulating Nucl...

Full description

Bibliographic Details
Main Authors: Zining Qi, Yi Li, ZhengKun Wang, Xuerong Tan, Yixuan Zhou, Zhendong Li, Weirong Zhao, Xin Zheng, Jicheng Yao, Feng Li, Weifeng Wang, Zhizheng Wang, Fei Pang, Gang Wang, Weiguang Gu
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Cancer Medicine
Subjects:
circulating tumor DNA
gastrointestinal carcinoma
molecular residual disease
tumor metastasis
Online Access:https://doi.org/10.1002/cam4.6286

Internet

https://doi.org/10.1002/cam4.6286

Similar Items